• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/84

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

84 Cards in this Set

  • Front
  • Back
Sedatives, formerly known as __________, produce calmness and relaxation and are therefore AKA ___________.
1. minor tranquilizers
2. anxiolytic (antianxiety agents)
sedatives are not intended for ___________, as this use contributes to the abuse potential
stress and tension of everyday living
a sedative produces _______, while a hypnotic produces ___________, and all hypnotics are __________
1. calmness and relaxation
2. sleep
3. sedatives
Describe the stages of sleep:
1. Stage 0
2. Stage 1
3. Stage 2
4. REM sleep
1. awake
2. onset of sleep
3. light, restful sleep that makes up 50% of total sleeptime
4. 25% of total sleep time
with each sleep cycle, the ________ increases
amount of REM sleep
Do sedative-hypnotics tend to cause both physical and psychological dependence?
Yes (It can occur within 1-3 months)
Describe the dose-related effects of CNS depressants:
1. low doses
2. higher doses
3. highest doses
1. sedative
2. hypnotic
3. anesthetic
Are CNS depressants used to treat anxiety and/or insomnia?
No
CNS agents have a _______therapeutic index and exhibit ____________ activity
1. narrow
2. anticonvulsant
Barbituates are __________, which causes numerous drug interactions
inducers of the P450 system
ADR of barbituate sedative-hypnotics:
1. large doses lead to_______
2. chronic use leads to _______
3. barbituate abstinence syndrome?
1. prolonged CNS depression
2. tolerance, dependence, and withdrawal
3. life threatening condition involving convulsions and delirium
what are two components of barbituate tolerance?
-enzyme induction and CNS changes
how does overdose of barbituates lead to fatality?
depression of medullaryrespiratory and CV control centers leads to respiratory failure
barbituates have additive/synergistic CNS depression when used with __________
other depressants such as alcohol
indications for benzodiazepines?
insomnia (characterized by difficulty falling asleep, frequent nocturnal waking or early morning waking)
name three benzodiazepines used for insomnia?
Estrazolam, Triazolam, Flurazepam
benzodiazepines potentiate neuronal transmission involving pathways using _______ as an inhibitory neurotransmitter
GABA
There are two subtypes of the GABA-A receptor. Stimulation of which receptor results in sleep onset and cycle regulation?
-BZ1
which GABA-A receptor types are activated by benzodiazepines?
-all are activated nonspecifically, which accounts for the wide range of actions of benzodiazepines
1. which three agents can only activate one BZ binding site?
2. what does this binding account for?
1. Zolpidem, Zalepon, and Eszopiclone
2. relatively selective hypnotic action and lack of anticonvulsant and muscle relaxant effects
Both barbituates and benzodiazepines have additive/synergistic effects with other CNS depressants, which has more CNS depressant activity?
barbituates
Give three reasons why barbituates are more likely to be CNS depressants
1. they bind to specific receptors that are different from BZ receptors
2. Direct GABAmimetic activity at higher concentrations
3. Inhibition of excitatory CNS neurotransmitters
How do BZs affect sleep patterns?
-decrease stages 0 and 1 and the # of wakenings
-increase stage 2 and REM sleep
-onset of REM is delayed and dreaming is diminished
how soon does tolerance develop to benzos?
several weeks
which type of benzos are best at achieving rapid onset, duration through the night, and no residual hangover?
short-acting and medium-acting
__________is a short-acting benzo that is associated with rebound insomnia and early morning awakening
Triazolam
name two intermediate acting benzos?
estazolam and temazepam
_____________is a long-acting benzo agent with an active metabolite that has a long half-life
Flurazepam
which benzo agent has increased daytime anxiety after ten days of continuous use due to tolerance and "interdose withdrawal"?
triazolam
name an ADR of triazolam that is considered to be a class effect of benzos
anterograde amnesia
describe the withdrawal symptoms related to physical dependence on benzos and the method of discontinuance
-muscle cramps, tremors, convulsion
-gradual withdrawal with a tapering schedule lasting > 2wks
which nonbarbiturate, nonbenzo sedative-hypnotic agents are approved for short-term tx of insomnia? (2)
-zolpidem and zaleplon
which nonbarbiturate, nonbenzo sedative-hypnotic agents are approved for tx of insomnia? (3)
-zolpidem ER, eszopiclone, and ramelteon
chloral hydrate is rapidly absorbed and metabolized to its active metabolite, ___________
trichloroethanol
trichloroethanol,active metabolite of chloral hydrate, has what effects of sudden withdrawal/detoxification?
seizures, hallucinations, and delirium
describe the interaction between chloral hydrate with alcohol and CNS depressants
-additive/synergistic effects because they competitively inhibit each other's metabolism
zolpidem is a _______receptor agonist that preferentially interacts with __________receptor subtypes
1. benzodiazepine
2. BZ1
does the dose at which zolpidem exerts hypnotic effects cause anxiolytic, anticonvulsant, and muscle relaxant effects?
nope
how does zolpidem affect the sleep cycle?
-decreases sleep latency (stage 1)
-increases total sleep time and duration
therapy with zolpidem should be limited to what time period?
7-10 days
which ADR appear to be minimal with Zolpidem?
tolerance, dependence, withdrawal, and rebound insomnia
__________is the first and only ER sleep med that promotes falling asleep and maintaining sleep with no significant decrease in next-day performance.
Zolpidem tartrate ER
indication for zolpidem tartrate ER
-tx of insomnia characterized by difficulties with sleep onset and/or sleep maintenance
-not limited to short-term tx
MOA of Zaleplon
-BZ1 receptor agonist
-shortens time to sleep onset
-DOES NOT increase sleep duration or reduce # of awakenings
administration/dosing of zaleplon
-admin immediately at bedtime or up to 4 hr prior to anticipated wake time for difficulty falling asleep
-does not cause residual sedation and next-morning memory impairment when dosed in middle of the night
what kind of agent is eszopliclone?
active S-isomer of the hypnotic zopiclone (a BZ1 receptor agonist)
characteristics of eszopiclone:
1. effects on insomnia
2. ADR
3. limited to short term use?
1.improves all components of insomnia
2. less likely to cause ADR such as dependence, abuse potential, residual daytime psychomotor and memory impairment
3. no
___________is a selective melatonin receptor agonist that stimulates type 1 (MT1).
ramelteon
indication for ramelteon
-adult insomnia characterized by difficulty with sleep onset
-not limited to short term use
is ramelteon a controlled substance? Why or why not?
-no-it has no evidence of abuse potential ordependence
what are the pharmacological actions that benzodiazepine anxiolytics share?
-hypnotic, anxiolytic,anticonvulsant, muscle relaxant, amnesiac
what are the advantages of benzodiazepine anxiolytics?
-rapid onset, high therapeutic index, and relatively few ADR
what are the disadvantages of benzodiazepine anxiolytics
-tolerance, impaired psychomotor skills, dependence (so D/c gradually)
GAD::
1. 1st lline drugs
2. 2nd line drugs
3. when would you use benzos?
1. antidepressants
2. buspirone
3. for acute relief or if symptoms warrant
DOC of relieving stress-related anxiety related to major life stressful events
-benzos
-especially effective for insomnia and restlessness
Panic D/O::
1. 1st line drug and time to improved symptoms?
2. 2nd line drug and which one is effective within days?
1. SSRIs-2-3 wks
2, BZs-alprazolam
PTSD DOC
SSRIs
Alcohol Withdrawal Syndrome::
1. symptoms within 1st 2 days?
2. within 1st 3 days?
1. tonic-clonic seizures
2, delirium tremens-hyperthermia, tachycardia, delirium, and hallucinations
AWS::
1. DOC
2. agents with fewer rebound effects and withdrawal seizures
3. agents that do not undergo hepatic metabolism, metabolized to inactive compounds, and short duration of action?
4. what dose for elderly or pts with hepatic dz?
1. BZs
2. Chlordiazepoxide and Diazepam (longer-acting)
3. Lorazepam and Oxazepam(short-acting)
4. 50% pf dose used in younger pts
indications for diazepam
-muscle relaxant, anticonvulsant, and preoperative medication
indications for lorazepam?
-preanestheic med to produce sedation and amnesia, status epilepticus
indications for alprazolam?
-panic D/O w/wo agoraphobia
indications for chlordiazepoxide?
acute alcohol withdrawal
MOA of BZs
-GABA-A rec is liandgated ion channel that when activated opens and allows chloride ion influx
-accumulation of chloride anions causes hyperpolarization of cell
-decreases/interrupts synaptic and neuronal transmission
GABA-A rec contains _________binding sites for BZs, therefore BZs act as ___________of GABA activity
1. three
2. allosteric modulators (frequency of Cl channel opening is increased adn GABA activity is enhanced but in absence of GABA they have no action)
pharmacological actions of BZs produced by activation of GABA-A rec? (3)
-hypnotic, anticonvulsant, and muscle relaxant
what are the effects that occur at BZ doses beyond those needed for anxiolytic and amnesic effects?
ataxia and sedation
Therapeutic index of BZs
-wide (high)
IM admin of diazepam and clordiazepoxide is poorly absorbed due to ___________and peak levels are __________and ___________compared to oral dosing
1. poorly absorbed due to precipitation in muscle causing slow erratic absorption
2. lower
3. take longer to reach
___________is a common active metabolite for several BZs, including diazepam and accumulation of this can occur with chronic dosing and cause___________
1. desmethyldiazepam
2. oversedation and ataxia
withdrawal symptoms for BZs
-muscle cramps, tremor, tonic-clonic seizures
ADR for BZs
CNS depression (drowsiness, sedation, lethargy, impaired psychomotor performance)
results of overdose of BZs
-only mild respiratory suppresion, unless taken with alcohol which can be fatal
additive/synergistic effects of BZs and other CNS depressants can lead to ________
severe ataxia
only approved indication for buspirone?
-mgmt of anxiety d/o or short-term relief of anxiety
MOA of buspirone
-reduces serotonergic activity in states of serotonin excess
-partial agonist for serotonin postsynaptic receptors
-antagonist in presence of 5HT
-full agonist at 5HT1A presynaptic receptors(inhibits 5HT release)
what is the significance of buspirone not binding to BZ receptors or affecting GABAergic transmission?
- no anticonvulsant or muscle relaxant effects
- lacks prominent sedative effects of other anxiolytics
-does not exhibit cross-tolerance with BZs and other sedative/hypnotics
optimal result with buspirone require tx for how long?
3-4wks
what can happen as a result for buspirone's affinity for DA receptors?
-potential to cause symptoms of dopamine blockade
DI of buspirone?
-MAOIs contraindicated
-P450 can cause buspirone to elevate up to 13x, causing drowsiness and dizziness
effects of abrupt discontinuation of buspirone?
none
MOA of Flumazenil
-BZ receptor competitive antagonist
-does NOT reverse effects of ethanol, barbituates, opioids,or general anesthetics
indications for flumazenil
-complete or partial reversal of sedative effects of BZs where::
-general anesthesia induced or maintained with BZs
-sedation prod by BZs for diagnostic and therapeutic procedures
-mgmt of BZs overdose is necessary (as adjunct to supportive measures)
primary ADR of flumazenil
-risk of seizures due to reversal of BZ effects in high risk populations:
-concurrent sedative-hypnotic w/d
-concurrent tricyclic antidepressant poisoning
-physical dependence on BZs